Jobs / United States / Glaxosmithkline LLC
Business Unit Head Oncology
Glaxosmithkline LLC · 🇺🇸 Vallensbaek Strand Delta Park
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Sr Manager - Oncology Commercial Analytics, Multiple Myeloma” (Data Scientists) in PA: $135k–$135k, median $135k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centered on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems. Our diverse portfolio consists of oncology-hematology, vaccines, respiratory-immunology-inflammation, and HIV medicines. Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges. Job purpose As Business Unit Head, Oncology, you will lead the Oncology Business Unit in Denmark, with accountability for strategy, commercial performance and people leadership. You will: • Lead the Oncology Business Unit in Denmark, shaping strategy, performance and people • Build, inspire and develop a high-performing commercial team across Sales and Marketing • Collaborate closely with Medical, Market Access, Supply and country leadership to deliver sustainable growth, prepare for launches and improve patient outcomes. This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: • Lead the commercial P&L, manage budgets and prioritise investment across channels • Build, coach and develop the commercial team with strong scientific and omnichannel skills • Set the strategic direction, drive launch readiness and execution plans to achieve the objectives • Build trusted external relationships with healthcare professionals, payers and patient groups • Be an active member of the Danish Leadership Team (DLT) • Ensure compliant, ethical conduct and strong risk management in all external activities. Additional information: • Position level: Director • Reporting line: General Manager Denmark • Primary location: Vallensbaek Strand Delta Park (Denmark) • Secondary location: Not applicable • Presence onsite: hybrid • People management: Approximately eight (8) direct reports • Business travel: limited Why You? Basic Qualification We are seeking professionals with the following required skills and qualifications to help us achieve our goals • Master’s degree in a relevant field, such as Business, Science, Pharmacy or a related discipline • A minimum of 10 years’ experience in comparable leadership roles within the pharmaceutical industry • Proven experience in Oncology and / or Hematology • Demonstrated people-leadership experience, including responsibility for Sales and Marketing teams • Experience leading product launches or major brand life-cycle initiatives • Strong commercial acumen, including experience managing a P&L or significant budgets • A strong track record in account management, omnichannel marketing and sales force effectiveness • Fluency in written and spoken English. Preferred Qualification If you have the following characteristics, it would be a plus • An advanced degree, such as an MBA or PhD, in a relevant field • Experience working with Market Access, Health Economics or payer strategy • Demonstrated ability to lead effectively across matrixed, cross-functional teams • Fluency in Danish and previous experience in the Danish market • Global and / or regional and / or Above market experience. What we value in you • A clear, people-first leadership style that develops others and drives accountability • The ability to make evidence-based decisions and act with appropriate speed • Strong communication and stakeholder-engag